Borrelia burgdorferi

(redirected from B. burgdorferi)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

Borrelia burgdorferi

[bə¦rēl·yə ‚bərg′dȯr·fə·rē]
(microbiology)
A gram-negative, helically shaped bacterium that is the causative agent of Lyme disease.
Mentioned in ?
References in periodicals archive ?
garinii infections from the same area and with those of patients who experienced B.
Canine seroprevalence of Borrelia burgdorferi and Anaplasma phagocytophilum and Lyme diseases vaccination status, Maine, USA, 2007 B.
Nine of the ospA haplotypes in the samples from the Midwest also are found in B.
Pharmasan Labs' iSpot Lyme test is a highly sensitive test to identify B.
As researchers learned more and more about the nature of Borrelia antigen expression, and with the availability of recombinant and synthetic B.
In Europe, Lyme arthritis can be caused by several genospecies of B.
The test uses a method already approved and sanctioned by the FDA and CDC for assessing a tuberculosis infection and simply applies it to the Lyme bacteria B.
The BBI Borrelia burgdorferi IgM and IgG Western Blot Test Kit is intended for use in testing human serum samples that have been found positive or equivocal using a first-line test (enzyme immunoassay or immunofluorescence assay) for B.
John Nowakowski of the Westchester Medical Center in Valhalla, NY, and members of the Lyme Disease Study Group, who compared different diagnostic modalities for the detection of B.
The vaccine that is used to immunize people produces antibodies to a protein that sits on the outside of B.